These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34964599)

  • 61. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies.
    Reuter N; Chen X; Kropff B; Peter AS; Britt WJ; Mach M; Überla K; Thomas M
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515187
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.
    Gorshkov K; Susumu K; Chen J; Xu M; Pradhan M; Zhu W; Hu X; Breger JC; Wolak M; Oh E
    ACS Nano; 2020 Sep; 14(9):12234-12247. PubMed ID: 32845122
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
    Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
    EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
    Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF
    J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MVsim is a toolset for quantifying and designing multivalent interactions.
    Bruncsics B; Errington WJ; Sarkar CA
    Nat Commun; 2022 Sep; 13(1):5029. PubMed ID: 36068204
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An Experimental Framework for Developing Point-of-Need Biosensors: Connecting Bio-Layer Interferometry and Electrochemical Impedance Spectroscopy.
    Ullah SF; Moreira G; Datta SPA; McLamore E; Vanegas D
    Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-SARS-CoV-1 and -2 nanobody engineering towards avidity-inspired therapeutics.
    Obeng EM; Dzuvor CKO; Danquah MK
    Nano Today; 2022 Feb; 42():101350. PubMed ID: 34840592
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    Bruncsics B; Errington WJ; Sarkar CA
    bioRxiv; 2021 Aug; ():. PubMed ID: 34373856
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel sensor-integrated proteome on chip (SPOC) platform with thousands of folded proteins on a 1.5 sq-cm biosensor chip to enable high-throughput real-time label-free screening for kinetic analysis.
    Agu CV; Cook RL; Martelly W; Gushgari LR; Mohan M; Takulapalli B
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328216
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correction to: SARS-CoV-2 S-Protein-Ace2 Binding Analysis Using Surface Plasmon Resonance.
    Baardsnes J; Paul-Roc B
    Methods Mol Biol; 2024; 2762():C1. PubMed ID: 39009937
    [No Abstract]   [Full Text] [Related]  

  • 72. Real-time detection of virus antibody interaction by label-free common-path interferometry.
    Alhaddad S; Bey H; Thouvenin O; Boulanger P; Boccara C; Boccara M; Izeddin I
    Biophys Rep (N Y); 2023 Sep; 3(3):100119. PubMed ID: 37662577
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2.
    Verstraete MM; Heinkel F; Li J; Cao S; Tran A; Halverson EC; Gene R; Stangle E; Silva-Moreno B; Arrafi S; Bavananthasivam J; Fung M; Eji-Lasisi M; Masterman S; Xanthoudakis S; Dixit S; Babcook J; Clavette B; Fogg M; Escobar-Cabrera E
    MAbs; 2023; 15(1):2212415. PubMed ID: 37229608
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mass spectrometry-based methods to characterize highly heterogeneous biopharmaceuticals, vaccines, and nonbiological complex drugs at the intact-mass level.
    Kaltashov IA; Ivanov DG; Yang Y
    Mass Spectrom Rev; 2024; 43(1):139-165. PubMed ID: 36582075
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Framework for Biosensors Assisted by Multiphoton Effects and Machine Learning.
    Arano-Martinez JA; Martínez-González CL; Salazar MI; Torres-Torres C
    Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140093
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasmonic Approaches for the Detection of SARS-CoV-2 Viral Particles.
    Szunerits S; Saada H; Pagneux Q; Boukherroub R
    Biosensors (Basel); 2022 Jul; 12(7):. PubMed ID: 35884352
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biosensor-Enabled Deconvolution of the Avidity-Induced Affinity Enhancement for the SARS-CoV-2 Spike Protein and ACE2 Interaction.
    Gutgsell AR; Gunnarsson A; Forssén P; Gordon E; Fornstedt T; Geschwindner S
    Anal Chem; 2022 Jan; 94(2):1187-1194. PubMed ID: 34964599
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Biosensor Assay Based on Coiled-Coil-Mediated Human ACE2 Receptor Capture for the Analysis of Its Interactions with the SARS-CoV-2 Receptor Binding Domain.
    Forest-Nault C; Koyuturk I; Gaudreault J; Pelletier A; L'Abbé D; Cass B; Bisson L; Burlacu A; Delafosse L; Stuible M; Henry O; De Crescenzo G; Durocher Y
    Methods Mol Biol; 2024; 2762():89-105. PubMed ID: 38315361
    [TBL] [Abstract][Full Text] [Related]  

  • 79. SARS-CoV-2S-Protein-Ace2 Binding Analysis Using Surface Plasmon Resonance.
    Baardsnes J; Paul-Roc B
    Methods Mol Biol; 2024; 2762():71-87. PubMed ID: 38315360
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
    Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
    Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.